Swiss National Bank Zai Lab LTD Transaction History

Swiss National Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$30.21 - $48.1 $725,040 - $1.15 Million	24,000 Added 10.84%	245,371 $8.16 Million
Q4 2022 Feb 08, 2023	SELL	$22.28 - $38.71 $8,912 - $15,484	-400 Reduced 0.18%	221,371 $6.8 Million
Q3 2022 Nov 09, 2022	BUY	$34.2 - $51.69 $68,400 - $103,380	2,000 Added 0.91%	221,771 $7.59 Million
Q2 2022 Aug 09, 2022	BUY	$23.14 - $49.68 $242,970 - $521,640	10,500 Added 5.02%	219,771 $7.62 Million
Q1 2022 May 09, 2022	BUY	$27.77 - $64.4 $733,128 - $1.7 Million	26,400 Added 14.44%	209,271 $9.2 Million
Q4 2021 Feb 08, 2022	SELL	$54.9 - $105.21 $10,980 - $21,042	-200 Reduced 0.11%	182,871 $11.5 Million
Q3 2021 Nov 08, 2021	BUY	$105.0 - $178.37 $609,000 - $1.03 Million	5,800 Added 3.27%	183,071 $19.3 Million
Q2 2021 Aug 06, 2021	BUY	$125.11 - $180.0 $100,088 - $144,000	800 Added 0.45%	177,271 $31.4 Million
Q1 2021 May 07, 2021	BUY	$126.27 - $191.71 $1.01 Million - $1.53 Million	8,000 Added 4.75%	176,471 $23.5 Million
Q4 2020 Feb 05, 2021	BUY	$81.94 - $135.34 $2.59 Million - $4.28 Million	31,600 Added 23.09%	168,471 $22.8 Million
Q3 2020 Nov 09, 2020	BUY	$73.3 - $89.48 $2.71 Million - $3.31 Million	36,966 Added 37.0%	136,871 $11.4 Million
Q2 2020 Aug 05, 2020	BUY	$48.82 - $82.53 $3.42 Million - $5.78 Million	70,005 Added 234.13%	99,905 $8.21 Million
Q1 2020 May 08, 2020	BUY	$39.1 - $62.9 $1.17 Million - $1.88 Million	29,900 New	29,900 $1.54 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.